ICY:FRA
Incyte Corp
€107,75
arrow_downward
-0,83%(-0,90) 1D
30 Sep., 08:00:43 GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ICY...
Open
€107,75
High
€107,75
Low
€107,75
Mkt. cap
24,97 mjd
Avg. vol.
25,00
Volume
0,00
52-wk high
€115,40
52-wk low
€70,22
No. of employees
3 k
Open
€107,75
High
€107,75
Low
€107,75
Mkt. cap
24,97 mjd
Avg. vol.
25,00
Volume
0,00
52-wk high
€115,40
52-wk low
€70,22
No. of employees
3 k
News stories
From web sources and news partners
The Global Legal Post
·
11 uur gelede
Diabetes tech company MiniMed hires ex-Incyte GC as next legal head
AD HOC NEWS
·
1 dag gelede
Incyte stock trades at EUR 110.18 after an Atebrioz target hike
Stock Titan
·
2 dae gelede
A legal chief with more than 25 years in pharma and biotech joins MiniMed.
Investing.com
·
2 dae gelede
H.C. Wainwright raises Incyte stock price target on Atebrioz approval
Profile
Incyte Corporation is an American multinational pharmaceutical company with headquarters in Wilmington, Delaware. The company currently operates manufacturing and R&D locations in North America, Europe, and Asia.
Incyte Corporation currently develops and manufactures prescription biopharmaceutical medications in multiple therapeutic areas including oncology, inflammation, and autoimmunity. Wikipedia
About Incyte Corp
CEO-
Employees2,84 k
Founded2002
HeadquartersWilmington, Delaware, Verenigde State van Amerika
Sector-
Websiteincyte.com